SCHEMBL207133

SCHEMBL207133

CN(C)C1(c2cccs2)CCC(NC(=O)CCC(=O)NCCc2cccc(Cl)c2)CC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.50
KMT2A Q03164 3/20 0.50
SMN1; SMN2 Q16637 4/20 0.48
NPC1 O15118 2/20 0.48
RAB9A P51151 2/20 0.48
HTT P42858 1/20 0.48
HPGD P15428 3/20 0.43
MEN1 O00255 1/20 0.43
EPHX2 P34913 1/20 0.43
THRB P10828 1/20 0.43
OPRM1 P35372 4/20 0.42
OPRL1 P41146 4/20 0.42
TAAR1 Q96RJ0 2/20 0.41
GLA P06280 1/20 0.41
RXFP1 Q9HBX9 1/20 0.41
MAPT P10636 1/20 0.41
PLAAT3 P53816 1/20 0.39
PLAAT5 Q96KN8 1/20 0.39
PLAAT2 Q9NWW9 1/20 0.39
PLAAT4 Q9UL19 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL208760 0.87 SMYD3 (0.48) NPC1RAB9AHTTOPRM1OPRL1
SCHEMBL208501 0.86 OPRM1 (0.60) ALDH1A1KMT2ASMN1; SMN2NPC1RAB9A
SCHEMBL206686 0.86 KMT2A (0.42) ALDH1A1KMT2ANPC1RAB9AHTT
SCHEMBL207653 0.84 OPRM1 (0.43) SMN1; SMN2NPC1RAB9AHPGDOPRM1
SCHEMBL206898 0.83 OPRM1 (0.60) NPC1EPHX2OPRM1OPRL1
SCHEMBL205735 0.82 ALDH1A1 (0.55) ALDH1A1KMT2ASMN1; SMN2NPC1RAB9A
SCHEMBL208376 0.82 OPRM1 (0.44) ALDH1A1KMT2ANPC1RAB9AHPGD
SCHEMBL207444 0.82 ALDH1A1 (0.45) ALDH1A1KMT2ASMN1; SMN2NPC1RAB9A
SCHEMBL207464 0.81 EPHX2 (0.45) SMN1; SMN2HPGDEPHX2OPRM1OPRL1
SCHEMBL206160 0.80 ALDH1A1 (0.49) ALDH1A1KMT2ASMN1; SMN2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8088763-B2 e.g. N-[1-(2,6-dichloro-benzyl)-pyrrolidin-3-yl]-N'-[4-dimethylamino-4-(4-methyl-benzyl)-cyclohexyl]-succinamide; noradrenaline and serotonin reuptake ihibitor; opioid ORL-1 receptor ligand; analgesic, antidepressant, anxiolytic agent, neurodegenerative diseases GRUENENTHAL GMBH (DE) 2012-01-03 US claimed
EP-1745010-B1 SUBSTITUTED CYCLOHEXYL-1,4-DIAMINE DERIVATIVES GRUENENTHAL GMBH (DE) 2009-08-05 EP claimed
US-20070112007-A1 Cyclohexyl-1, 4-diamine compounds GRUENENTHAL GMBH (DE) 2007-05-17 US claimed
US-8088763-B2 e.g. N-[1-(2,6-dichloro-benzyl)-pyrrolidin-3-yl]-N'-[4-dimethylamino-4-(4-methyl-benzyl)-cyclohexyl]-succinamide; noradrenaline and serotonin reuptake ihibitor; opioid ORL-1 receptor ligand; analgesic, antidepressant, anxiolytic agent, neurodegenerative diseases GRUENENTHAL GMBH (DE) 2012-01-03 US disclosed
EP-1745010-B1 SUBSTITUTED CYCLOHEXYL-1,4-DIAMINE DERIVATIVES GRUENENTHAL GMBH (DE) 2009-08-05 EP disclosed
US-20070112007-A1 Cyclohexyl-1, 4-diamine compounds GRUENENTHAL GMBH (DE) 2007-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070112007-A1 Cyclohexyl-1, 4-diamine compounds PKD1, DDC, DPYD ALDH1A1 158/4885KMT2A 3604/4885SMN1; SMN2 1061/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.